Clinical Trial Update: Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the safety and efficacy of DWN12088 in patients with idiopathic pulmonary fibrosis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• DWN12088

Snippet

Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: Idiopathic Pulmonary Fibrosis | Phase 2 | Status: RECRUITING